1255717-98-6

Basic information

• Product Name: 1-(3-Chloropropyl)-1H-pyrazole hydrochloride
• Synonyms: 1-(3-Chloropropyl)-1H-pyrazole hydrochloride;1-(3-Chloropropyl)-1H-Pyrazole Hydrochloride(WX630289)
• CAS NO: 1255717-98-6
• Molecular Formula: C6H10Cl2N2
• Molecular Weight: 181.063
• Mol File: 1255717-98-6.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-(3-Chloropropyl)-1H-pyrazole hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(3-Chloropropyl)-1H-pyrazole hydrochloride(1255717-98-6)
• EPA Substance Registry System: 1-(3-Chloropropyl)-1H-pyrazole hydrochloride(1255717-98-6)

Safety Data

• Hazardous Substances Data: 1255717-98-6(Hazardous Substances Data)

Usage

Description

1-(3-Chloropropyl)-1H-pyrazole hydrochloride is an organic compound that serves as an intermediate in the synthesis of various pharmaceuticals and chemical compounds. It is characterized by its unique structure, which includes a pyrazole ring and a chloropropyl group, making it a versatile building block for the development of new drugs and materials.

Uses

Used in Pharmaceutical Industry:
1-(3-Chloropropyl)-1H-pyrazole hydrochloride is used as a key intermediate in the preparation of heteroaryl-carboxamides, which are known as histone demethylase inhibitors. These inhibitors play a crucial role in the regulation of gene expression and have potential applications in the treatment of various diseases, including cancer and neurological disorders.
In the synthesis of heteroaryl-carboxamides, 1-(3-chloropropyl)-1H-pyrazole hydrochloride serves as a valuable precursor, allowing for the creation of diverse chemical structures with potential therapeutic properties. Its reactivity and functional groups enable the formation of new bonds and the attachment of various heteroaryl moieties, leading to the development of novel histone demethylase inhibitors with improved efficacy and selectivity.
Overall, 1-(3-chloropropyl)-1H-pyrazole hydrochloride is an essential component in the advancement of pharmaceutical research, particularly in the discovery and development of new histone demethylase inhibitors with potential applications in various therapeutic areas.